Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1724-1731, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, M. G.
Right arrow Articles by Monk, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, M. G.
Right arrow Articles by Monk, T. G.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
Right arrow Hematology
Right arrow Oak Ridge Conference
(Clinical Chemistry. 1997;43:1724-1731.)
© 1997 American Association for Clinical Chemistry, Inc.


Oak Ridge Conference

Blood substitutes: evolution and future applications

Mitchell G. Scott, Dennis F. Kucik, Lawrence T. Goodnough and Terri G. Monka

a Author for correspondence. Fax 314-747-1716; e-mail monkt{at}notes.wustl.edu


Abstract

The development of oxygen-carrying blood substitutes has progressed significantly in the last decade with phase I and phase II clinical trials of both hemoglobin-based and perfluorocarbon-based oxygen carriers nearing completion. As these products approach clinical use it is important for the laboratory medicine community to be aware of their effects on routine laboratory testing and the settings in which they might be used. Here we review the forces driving the development of oxygen-carrying blood substitutes, the clinical settings in which they might be used, the major categories of oxygen carriers in clinical trials, and the challenges faced by these products as they approach clinical use.




The following articles in journals at HighWire Press have cited this article:


Home page
Anesth. Analg.Home page
R. J. Frumento, L. Mongero, Y. Naka, and E. Bennett-Guerrero
Preserved Gastric Tonometric Variables in Cardiac Surgical Patients Administered Intravenous Perflubron Emulsion
Anesth. Analg., April 1, 2002; 94(4): 809 - 814.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. A. Ali, G. S. Ali, J. M. Steinke, and A. P. Shepherd
Co-Oximetry Interference by Hemoglobin-Based Blood Substitutes
Anesth. Analg., April 1, 2001; 92(4): 863 - 869.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Mullon, G. Giacoppe, C. Clagett, D. McCune, and T. Dillard
Transfusions of Polymerized Bovine Hemoglobin in a Patient with Severe Autoimmune Hemolytic Anemia
N. Engl. J. Med., June 1, 2000; 342(22): 1638 - 1643.
[Full Text] [PDF]


Home page
NEJMHome page
L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. AuBuchon
Transfusion Medicine -- Blood Conservation- Second of Two Parts
N. Engl. J. Med., February 18, 1999; 340(7): 525 - 533.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Caron, P. Menu, B. Faivre-Fiorina, P. Labrude, A. I. Alayash, and C. Vigneron
Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits
J Appl Physiol, February 1, 1999; 86(2): 541 - 548.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
E. M. KEATING
Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*{{dagger}}
J. Bone Joint Surg. Am., May 1, 1998; 80(5): 750 - 62.
[Full Text]


Home page
Clin. Chem.Home page
Z. Ma, T. G. Monk, L. T. Goodnough, A. McClellan, M. Gawryl, T. Clark, P. Moreira, P. E. Keipert, and M. G. Scott
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests
Clin. Chem., September 1, 1997; 43(9): 1732 - 1737.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.